Blog

To prevent an emerging genomic technology from contributing to health disparities, a scientific team funded by the National Institutes of Health has devised new ways to improve a genetic testing method called a polygenic risk score. Since polygenic risk scores have not been effective for

MIAMI, FLORIDA (Feb. 15, 2024) – Prominent oncologist and researcher Damian Green, M.D., will join Sylvester Comprehensive Cancer Center at the University Miami Miller School of Medicine this spring to lead its transplantation and cellular therapy services. Credit: Sylvester Comprehensive Cancer Center MIAMI, FLORIDA (Feb.

A study co-led by Professor Kelly Metcalfe of the Lawrence Bloomberg Faculty of Nursing, and researchers at the Familial Breast Cancer Research Unit at Women’s College Hospital, finds risk-reducing mastectomies (RRM) in women with a BRCA1 or BRCA2 genetic variant, significantly reduces the risk of

Reston, VA—Nuclear medicine has the potential to change the landscape of theranostics in neurooncology, according to a new article published in the February issue of The Journal of Nuclear Medicine (JNM). With recent advances in techniques to permeate the brain-blood barrier (BBB), the prospect of using

Lung cancer is one of the most common cancers and has one of the lowest survival rates in the world. Cytokines, which are small signaling proteins, such as interleukin-12 (IL-12), have demonstrated considerable potential as robust tumor suppressors. However, their applications are limited due to

The Blood Cancer Healing Center, located at 3229 Burnet Avenue in Uptown Cincinnati, is poised to redefine care standards by offering comprehensive patient support and innovative treatments under one roof. With clinical services opening as part of a phased approach in the summer of 2024,

LOS ANGELES — City of Hope®, one of the largest cancer research and treatment organizations in the United States, treated the oldest person to be cured of a blood cancer and then achieve remission for HIV after receiving a blood stem cell transplant from a

“Our study was designed to build specific mutational and therapeutic landscapes of pancreatic cancer among the Russian population.” Credit: 2024 Shatalov et al. “Our study was designed to build specific mutational and therapeutic landscapes of pancreatic cancer among the Russian population.” BUFFALO, NY- February 14,

Montreal, February 14, 2024—Canadian researchers led by Montreal radiologist Gilles Soulez have developed a novel approach to treat liver tumours using magnet-guided microrobots in an MRI device. Credit: CHUM Montreal, February 14, 2024—Canadian researchers led by Montreal radiologist Gilles Soulez have developed a novel approach

  Credit: Laura M. Lombardía/CNIO Researchers at the Spanish National Cancer Research Center (CNIO) and the 12 de Octubre University Hospital have developed a new cell-based immunotherapy to treat multiple myeloma   The new immunotherapy is based on STAb cells and has yet to pass